Search
Showing results for "clinical trials"
The Healing Kids, Healing Families team strives to understand how trauma and adverse circumstances can impact a child and their family, and how we can help them to recover from these experiences.
Since 1955, the recommended strategy for rheumatic heart disease secondary prophylaxis has been benzathine penicillin G injections administered intramuscularly every 4 weeks. Due to dosing frequency, pain, and programmatic challenges, adherence is suboptimal. It has previously been demonstrated that BPG delivered subcutaneously at a standard dose is safe and tolerable and has favorable pharmacokinetics, setting the scene for improved regimens with less frequent administration.
Melissa Fiona Helen Rebecca Peter O'Donnell Stanley Leonard Glauert Jacoby BPsych (Hons), MPsych, GradDip Ed, PhD FAA FASSA MSc MD FFPHM FAFPHM FRACP
Honorary Research Associate
START Phage WA was formed to pave the way towards treating AMR infections with phage therapy in Western Australia.
This study aimed to acquire nationally representative epidemiological data on GAS in Australia to scope the appropriate age for vaccination with a potential...
This study was designed to compare data collected via SMS and telephone for the purposes of monitoring vaccine safety.
In Australia, following the introduction of serogroup C meningococcal (MenC) conjugate vaccine for toddlers and catch-up immunization through adolescence,...
In this study of healthy adults aged 50-85 and 18-24 years, SA3Ag elicited a rapid and robust immune response and was well tolerated, with no notable safety...
Febrile seizures (FS) are common in childhood with incidence peaking in the second year of life when measles and varicella-containing vaccines are administered.